Skip to main content

Middle East

Q&A: Andy Wright, Resnova

Andy Wright, co-founder of a new consultancy firm, Resnova, speaks to Insurance Post about his time at Tesla and Zego, why he wanted to set up a consultancy firm, and why he thinks the next wave of insurtech funding could be coming from China and the…

Allianz and Aviva drop Elbit cover

Allianz and Aviva have given pro-Palestine activists a win after dropping cover for Elbit Systems, the firm providing arms and fuel to Israel.

Big Interview: Andy Rice, Charles Taylor Adjusting

From a guitar-playing teenager to CEO of Charles Taylor Adjusting International, Andy Rice shares how his loss adjusting journey started in 1985 and outlines how he is orchestrating to growing the business globally in 2025.

Diary of an Insurer: Charles Taylor’s Jeremy Stevens

Jeremy Stevens, head of EMEA business at Charles Taylor InsureTech, keeps running up and down Crystal Palace’s hill, briefs the team on new client projects across the globe, and gets home in time to finish reading Fantastic Mr Fox with his daughter.

How worldwide events transform war and terrorism cover

In the latest Insurance Post Podcast, Thomas Clayton, head of cyber for Zurich UK, CFC’s terrorism and sabotage team leader Harry Salmon, and Hugh Sparks, managing director for onshore energy and mining at Charles Taylor Adjusting, reflect on how the…

Big Interview: ASL International’s Helen Meredith

Helen Meredith, managing director of ASL International, shares why she isn’t afraid of the ticking demographic time bomb scaring most loss adjusting firms and how the financial lines specialists intend to increase the amount of cyber and political risk…

Q&A: John Fowle, Chaucer

John Fowle, CEO of Chaucer, tells Post all about growth, being owned by China Re and the plans for the next 12 months as well as why the business undertook its recent rebranding and the importance of diversity and inclusion.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here